Peptide Therapy Providers in Las Cruces, New Mexico

1 provider found in Las Cruces · 1 offer telehealth · 1 free consultations

PeptideProbe lists 1 peptide therapy provider in Las Cruces, New Mexico. Whether you're researching GLP-1 weight-loss medications like semaglutide and tirzepatide, recovery peptides such as BPC-157, or hormone optimization protocols, you can compare clinics below by services offered, telehealth availability, insurance acceptance, and patient reviews. 1 offers a free initial consultation.

Most-offered peptides in Las Cruces: Semaglutide (1), Sermorelin (1), Tirzepatide (1), BPC-157 (1), Ipamorelin (1).

Las Cruces, NM
TelehealthFree Consult
SemaglutideSermorelinTirzepatideBPC-157Ipamorelin

Salud Healthcare is a nurse-owned clinic offering peptide therapy integrated into a whole-person, prevention-first medical model. Led by Genevieve Montoya, DNP, FNP-BC, they provide medical weight los

View Profile

Nearby Cities in New Mexico

Frequently Asked Questions

Peptide therapy costs in Las Cruces, New Mexico vary by treatment. Semaglutide typically costs $200-$500/month. Other peptides range from $100-$800/month depending on the specific therapy and provider.

Yes, 1 of 1 providers in Las Cruces Las Cruces, New Mexico offer telehealth services. This allows you to consult with practitioners remotely and have medications shipped directly to you.

Providers in Las Cruces commonly offer weight-loss peptides (semaglutide, tirzepatide), recovery peptides (BPC-157, TB-500), anti-aging treatments (NAD+, GHK-Cu), and hormone optimization therapies (sermorelin, CJC-1295).

Yes — peptide therapies in Las Cruces require a prescription from a licensed healthcare provider. This includes FDA-approved GLP-1 medications and compounded peptides from licensed pharmacies. All providers listed on PeptideProbe operate under licensed medical supervision.

Medical Disclaimer: This content is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare provider before beginning any peptide therapy treatment.